Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biomarin Pharmaceutical Inc
Non-Reccuring Items
Biomarin Pharmaceutical Inc
Non-Reccuring Items Peer Comparison
Competitive Non-Reccuring Items Analysis
Latest Figures & CAGR of Competitors
Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
Non-Reccuring Items
-$1.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
10%
|
|
Abbvie Inc
NYSE:ABBV
|
Non-Reccuring Items
-$3.2B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Non-Reccuring Items
-$7.2B
|
CAGR 3-Years
-766%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Non-Reccuring Items
$10m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Non-Reccuring Items
-$137.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biomarin Pharmaceutical Inc's Non-Reccuring Items?
Non-Reccuring Items
-1.9m
USD
Based on the financial report for Mar 31, 2024, Biomarin Pharmaceutical Inc's Non-Reccuring Items amounts to -1.9m USD.
What is Biomarin Pharmaceutical Inc's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
10%